Regulation of transcription factor function by purinergic signalling in cardiovascular diseases

• Published in: Purinergic signalling
• Main Authors: Tang, Hao, Kong, Qihang, Zhang, Zhewei, Wu, Wenchao, Yuan, Lixing, Liu, Xiaojing
• Format: Journal Article
• Language: English
• Published: Netherlands 31.08.2024
• Subjects: Purinergic receptors; Cardiovascular diseases; Transcription factor
• ISSN: 1573-9538; 1573-9546; 1573-9546
• DOI: 10.1007/s11302-024-10045-8

Cardiovascular diseases (CVDs), including hypertension, atherosclerosis, myocardial ischemia, and myocardial infarction, constitute the primary cause of mortality worldwide. Transcription factors play critical roles in the development of CVDs and contribute to the pathophysiology of these diseases by coordinating the transcription of many genes involved in inflammation, oxidative stress, angiogenesis, and glycolytic metabolism. One important regulator of hemostasis in both healthy and pathological settings has been identified as a purinergic signalling pathway. Research has demonstrated that several signalling networks implicated in the pathophysiology of CVDs are formed by transcription factors that are regulated by purinergic substances. Here, we briefly summarize the roles and mechanisms of the transcription factors regulated by purinergic pathways in various types of CVD. This information will be essential for discovering novel approaches for CVD treatment and prevention.